OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 153 filers reported holding OCULAR THERAPEUTIX INC in Q1 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,999 | -87.6% | 8,280 | -79.2% | 0.00% | -100.0% |
Q1 2023 | $209,440 | +238.9% | 39,742 | +80.7% | 0.00% | – |
Q4 2022 | $61,798 | -60.4% | 21,992 | -41.6% | 0.00% | – |
Q3 2022 | $156,000 | +225.0% | 37,689 | +214.9% | 0.00% | – |
Q2 2022 | $48,000 | +860.0% | 11,970 | +1031.4% | 0.00% | – |
Q1 2022 | $5,000 | -98.8% | 1,058 | -97.5% | 0.00% | – |
Q3 2021 | $425,000 | -63.8% | 42,495 | -48.6% | 0.00% | -100.0% |
Q2 2021 | $1,173,000 | +41.0% | 82,727 | +63.3% | 0.00% | 0.0% |
Q1 2021 | $832,000 | -36.6% | 50,675 | -20.1% | 0.00% | -50.0% |
Q4 2020 | $1,313,000 | +976.2% | 63,431 | +295.9% | 0.00% | – |
Q3 2020 | $122,000 | +713.3% | 16,023 | +226.5% | 0.00% | – |
Q3 2019 | $15,000 | -65.1% | 4,907 | -54.7% | 0.00% | – |
Q4 2018 | $43,000 | -64.5% | 10,827 | -38.4% | 0.00% | -100.0% |
Q3 2018 | $121,000 | +476.2% | 17,572 | +275.1% | 0.00% | – |
Q4 2017 | $21,000 | -30.0% | 4,684 | -3.5% | 0.00% | – |
Q3 2017 | $30,000 | -37.5% | 4,854 | -5.9% | 0.00% | -100.0% |
Q1 2017 | $48,000 | +37.1% | 5,160 | +22.7% | 0.00% | – |
Q4 2016 | $35,000 | -23.9% | 4,205 | -37.6% | 0.00% | – |
Q3 2016 | $46,000 | +70.4% | 6,742 | +250.6% | 0.00% | – |
Q3 2015 | $27,000 | – | 1,923 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 5,618,861 | $116,310,000 | 100.00% |
Opaleye Management Inc. | 6,510,000 | $134,758,000 | 17.60% |
DELTEC ASSET MANAGEMENT LLC | 2,168,573 | $44,889,000 | 6.87% |
Versant Venture Management, LLC | 1,465,384 | $30,333,000 | 3.15% |
GREAT POINT PARTNERS LLC | 856,162 | $17,723,000 | 2.88% |
Affinity Asset Advisors, LLC | 220,000 | $4,554,000 | 2.41% |
Altium Capital Management LP | 303,174 | $6,276,000 | 2.34% |
Endurant Capital Management LP | 290,465 | $6,013,000 | 2.17% |
MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 50,396 | $1,043,000 | 1.17% |
Lisanti Capital Growth, LLC | 366,040 | $7,577,000 | 1.05% |